Skip to main content
. 2021 Jan 14;13(1):99. doi: 10.3390/pharmaceutics13010099

Figure 11.

Figure 11

In vivo safety of the treatment. (A) Body weight changes in different groups during the treatment. (B) Organ coefficients. (C) RBCs, (D) WBCs, (E) HCT, (F) HGB, (G) H&E staining of main organs. Data were presented as mean SD (n = 6).